As always, we'll leave plenty of time to answer your questions.
Fred Hutch is at the center of a nonstop scientific sprint to understand and stop the coronavirus. Join us Tuesday, February 23, for Science Says, our monthly researcher roundtable, to meet scientists who are leading vaccine trials, guiding public health policy, tracking genetic changes to the virus, and studying new treatments for COVID-19.
Please RSVP by Monday, February 22. After you register, you will receive instructions for how to join the conversation by computer, tablet, or phone.
Dr. Thomas J. Lynch Jr., who will lead the conversation, is Fred Hutch president and holder of the Raisbeck Endowed Chair. He is a lung cancer physician and scientist who is respected worldwide for his pioneering role in precision medicine and his leadership in academic medicine and industry. He joined Fred Hutch one year ago — just weeks before COVID-19 shutdowns began — and has guided the organization’s response to the pandemic with urgency, compassion, and a commitment to sparking scientific solutions.
Dr. Michele Andrasik is one of the directors of the COVID-19 Prevention Network (CoVPN), which is conducting Phase 3 efficacy trials for vaccines as part of Operation Warp Speed. She has worked to ensure that communities hit hardest by COVID-19 are adequately represented in vaccine trials, and she helps create educational materials to increase understanding and uptake of approved vaccines.
Dr. Trevor Bedford is a computational biologist who has been at the forefront of tracking the virus that causes COVID-19 since it emerged. His expertise and insight, along with the software tool he co-developed, Nextstrain, have been instrumental to understanding the rapid spread and evolution of the coronavirus — and have earned him nearly 300,000 followers on Twitter.
Dr. Larry Corey is a world-renowned virologist, principal investigator of the HIV Vaccine Trials Network, and Fred Hutch president and director emeritus. As head of the COVID-19 Prevention Network operations center, located at Fred Hutch, and co-leader of the network’s massive clinical trials program, he plays a critical role in Operation Warp Speed, the nation’s monumental effort to develop, test, and distribute vaccines in record time.
Dr. Josh Schiffer is an infectious disease physician who uses computer modeling to study COVID-19 transmission and super-spreading. His research has reinforced the importance of widespread masking and testing, and he is a strong advocate for developing treatments that interrupt COVID-19 early in the course of infection. Dr. Schiffer is one of many researchers leading clinical trials at Fred Hutch’s new COVID-19 Clinical Research Center.